doi: 10.1016/j.molmet.2021.101367 162
Results vary between individuals and depend on medical eligibility, treatment adherence, lifestyle habits, and ongoing follow-up
She didnt think quitting the drugs would be that big of a deal: She had lost as much as she wanted to, and in her mind, the companys messaging throughout her two years had suggested that, unless you were a diabetic, there was no need to stay on the GLP-1. But Isherwood told Fortune that within six to eight months, she gained back about 20 pounds as she reverted to old behaviors when stressors arose in her lifea familiar pattern that shed experienced before
Research presented at the American Academy of Orthopaedic Surgeons meeting in March 2026 linked GLP-1 use to nearly double the risk of bone density issues over five years
The glycemic control benefits of semaglutide provide dual value for people managing blood sugar alongside weight
Increased hepcidin levels lead to ferroportin degradation, reducing iron absorption and recycling, whereas decreased hepcidin levels enhance iron release into circulation represented in Figure 1
